Form 4: Cardlytics CFO Alexis DeSieno Reports Stock Transactions
SEC Form 4 Filing
Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- Alexis DeSieno, CFO of Cardlytics, Inc. reported transactions involving Cardlytics' common stock on April 1, 2025, and April 2, 2025.
- On April 1, 2025, 14,350 restricted stock units (RSUs) vested, converting into common stock.
- On April 2, 2025, Ms. DeSieno sold 7,998 shares of common stock at a weighted average price of $1.806 per share.
- The sale was solely to satisfy tax withholding obligations resulting from the RSU vesting.
- Following these transactions, Ms. DeSieno directly owns 147,300 shares of Cardlytics common stock and 57,398 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing the CFO's transactions to those of peers at similar companies (e.g., LiveRamp, Epsilon) would provide context on whether these actions are typical or indicative of a specific trend.
- Analyzing the vesting schedules and stock ownership percentages relative to industry benchmarks can offer insights into the alignment of management incentives with shareholder value.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as the sale of shares to cover taxes is a routine event.
- Employees may be interested in the vesting schedule of RSUs as it relates to their own compensation packages.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | First vesting date of RSU award. |
| 10/01/2024 | Second vesting date of RSU award. |
| 01/01/2025 | Third vesting date of RSU award. |
| 04/01/2025 | RSU vesting date; 14,350 shares vested. |
| 04/01/2025 | Date of transaction involving the vesting of restricted stock units. |
| 04/02/2025 | Date of transaction involving the sale of common stock. |
| 04/03/2025 | Date of signature on the Form 4 filing. |
| 07/01/2025 | Fifth vesting date of RSU award. |
| 10/01/2025 | Sixth vesting date of RSU award. |
| 01/01/2026 | Seventh vesting date of RSU award. |
| 04/01/2026 | Final vesting date of RSU award. |
Keywords
Cardlytics, CDLX, Form 4, Insider Trading, Alexis DeSieno, CFO, Restricted Stock Units, Stock Sale, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.